Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat
- 2017-03-07
- Scientific Reports 7(1)
- E. Patterson
- E. Patterson
- R. Wall
- R. Wall
- Sara Lisai
- R. Ross
- T. Dinan
- J. Cryan
- G. Fitzgerald
- S. Banni
- E. Quigley
- F. Shanahan
- C. Stanton
- C. Stanton
- PubMed: 28265110
- DOI: 10.1038/srep43300
Abstract
This study focused on the mechanisms that fatty acid conjugating strains - Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 - influence lipid metabolism when ingested with α-linolenic acid (ALA) enriched diet. Four groups of BALB/c mice received ALA enriched diet (3% (w/w)) either alone or in combination with B. breve NCIMB 702258 or B. breve DPC 6330 (109 CFU/day) or unsupplemented control diet for six weeks. The overall n-3 PUFA score was increased in all groups receiving the ALA enriched diet. Hepatic peroxisomal beta oxidation increased following supplementation of the ALA enriched diet with B. breve (P < 0.05) and so the ability of the strains to produce c9t11 conjugated linoleic acid (CLA) was identified in adipose tissue. Furthermore, a strain specific effect of B. breve NCIMB 702258 was found on the endocannabinoid system (ECS). Liver triglycerides (TAG) were reduced following ALA supplementation, compared with unsupplemented controls (P < 0.01) while intervention with B. breve further reduced liver TAG (P < 0.01), compared with the ALA enriched control. These data indicate that the interactions of the gut microbiota with fatty acid metabolism directly affect host health by modulating n-3 PUFA score and the ECS.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bifidobacterium breve | Altered Endocannabinoid System Function Due to Specific Strain | Neutral | Small |
Bifidobacterium breve | Enhanced Hepatic Peroxisomal Beta Oxidation | Beneficial | Moderate |
Bifidobacterium breve | Increased c9t11 CLA Production in Adipose Tissue | Beneficial | Moderate |
Bifidobacterium breve | Increased n-3 Polyunsaturated Fatty Acid Levels | Beneficial | Moderate |
Bifidobacterium breve | Reduced Liver Triglyceride Content | Beneficial | Large |
Bifidobacterium breve R0070 | Enhanced Hepatic Peroxisomal Beta Oxidation | Beneficial | Moderate |
Bifidobacterium breve R0070 | Increased n-3 Polyunsaturated Fatty Acid Levels | Beneficial | Moderate |
Bifidobacterium breve R0070 | Modulated Endocannabinoid System | Beneficial | Moderate |
Bifidobacterium breve R0070 | Reduced Liver Triglyceride Content | Beneficial | Large |
Bifidobacterium breve Rosell-70 | Enhanced Hepatic Peroxisomal Beta Oxidation | Beneficial | Moderate |
Bifidobacterium breve Rosell-70 | Increased n-3 Polyunsaturated Fatty Acid Levels | Beneficial | Moderate |
Bifidobacterium breve Rosell-70 | Reduced Liver Triglycerides | Beneficial | Large |